EMR
May 7, 2025 - AI Summary
Overvalued by 60.9% based on the discounted cash flow analysis.
Market cap | $72.19 Billion |
---|---|
Enterprise Value | $86.41 Billion |
Dividend Yield | $2.1075 (1.64225044806359%) |
Earnings per Share | $3.44 |
Beta | 1.27 |
Outstanding Shares | 563,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 30.17 |
---|---|
PEG | -944.6 |
Price to Sales | 4.28 |
Price to Book Ratio | 3.9 |
Enterprise Value to Revenue | 4.91 |
Enterprise Value to EBIT | 34.45 |
Enterprise Value to Net Income | 36 |
Total Debt to Enterprise | 0.19 |
Debt to Equity | 0.84 |
No data
No data